Psilocybin has slowed down the aging process in cells and mice. It may be able to scale up to humans and help slow diseases ...

Supporters believe that FDA approval will make the drug more accessible. Right now, traditional psilocybin therapy offered at healing centers in the state is not covered by insurance.